In a preclinical study, UC Davis Comprehensive Cancer Center scientists developed a highly targeted gene therapy that could revolutionize treatment for cancers linked to a common herpesvirus, with minimal side effects.
The novel…
Highly targeted gene therapy could revolutionize treatment for cancers linked to herpesvirus
